MktsMarkets

Ernexa Therapeutics Inc.
NASDAQ: ERNAKey statistics
ERNA News
Stories mentioning ERNA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1.00 | 487.00 | 47.00 | |||||
| Cost of Goods Sold | 0.00 | (60.00) | 95.00 | |||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 547.00 | (48.00) |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 5,590 | 2,095 | 1,993 | 2,501 | 2,730 | 2,698 | 2,806 | 4,883 |
| Operating Income (Loss) | (5,590) | (2,095) | (1,993) | (2,501) | (2,730) | (2,697) | (2,259) | (4,931) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 479.00 | (6.00) | (123.00) | (135.00) | ||||
| Pretax Income | (5,546) | (1,565) | (1,234) | (3,136) | (8,194) | (5,748) | (26,592) | (5,526) |
| Tax Provision | (40.00) | (62.00) | 6.00 | 3.00 | 8.00 | 11.00 | 12.00 | 3.00 |
| Net Income (Loss) | (5,506) | (1,503) | (1,240) | (3,139) | (8,202) | (5,759) | (26,604) | (5,529) |
| Earnings Per Share (Basic) | (6.95) | (0.24) | (0.15) | (0.61) | (57.76) | (6.33) | (73.70) | (15.34) |
| Earnings Per Share (Diluted) | (6.95) | (0.24) | (0.15) | (0.61) | (57.76) | (6.33) | (73.70) | (15.34) |
| Weighted Average Shares Outstanding (Basic) | 792.00 | 6,307 | 8,226 | 5,179 | 142.00 | 910.00 | 361.00 | 361.00 |
| Weighted Average Shares Outstanding (Diluted) | 792.00 | 6,307 | 8,226 | 5,179 | 142.00 | 910.00 | 361.00 | 361.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ERNA
Ernexa Therapeutics Inc. (NASDAQ: ERNA) is a stock listed on the Nasdaq Stock Market under the ticker symbol ERNA. It last traded at $1.95 (Nov 2, 2026, 3:24 PM ET), down 1.0% on the day. That gives Ernexa Therapeutics a market capitalisation of $3.2M.
Over the past 52 weeks ERNA has traded between $1.84 and $48.00.
For the quarter ended Mar 31, 2026 it reported a net loss of $5.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$5.5M |
| Dec 31, 2025 | — | -$1.5M |
| Sep 30, 2025 | — | -$1.2M |
| Jun 30, 2025 | — | -$3.1M |
From Ernexa Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…